These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 31213788

  • 21. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis.
    Cheng SL.
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168
    [Abstract] [Full Text] [Related]

  • 22. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
    Morjaria JB, Rigby A, Morice AH.
    Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
    [Abstract] [Full Text] [Related]

  • 23. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD, Poole C, Webster S, Tebboth A, Dickinson S, Gayle A.
    Respir Res; 2018 Apr 11; 19(1):63. PubMed ID: 29642882
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
    Hurst JR, Dilleen M, Morris K, Hills S, Emir B, Jones R.
    Int J Chron Obstruct Pulmon Dis; 2018 Apr 11; 13():781-792. PubMed ID: 29551894
    [Abstract] [Full Text] [Related]

  • 27. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.
    Soriano JB, Sin DD, Zhang X, Camp PG, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Petersson S, Postma DS, Szafranski W, Vestbo J.
    Chest; 2007 Mar 11; 131(3):682-689. PubMed ID: 17356080
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD.
    Obeidat M, Faiz A, Li X, van den Berge M, Hansel NN, Joubert P, Hao K, Brandsma CA, Rafaels N, Mathias R, Ruczinski I, Beaty TH, Barnes KC, Man SFP, Paré PD, Sin DD.
    Eur Respir J; 2019 Dec 11; 54(6):. PubMed ID: 31537701
    [Abstract] [Full Text] [Related]

  • 31. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WM, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D.
    Int J Chron Obstruct Pulmon Dis; 2014 Dec 11; 9():1163-86. PubMed ID: 25378918
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.
    Zysman M, Deslee G, Caillaud D, Chanez P, Escamilla R, Court-Fortune I, Nesme-Meyer P, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N, Burgel PR.
    Int J Chron Obstruct Pulmon Dis; 2017 Dec 11; 12():1819-1824. PubMed ID: 28694695
    [Abstract] [Full Text] [Related]

  • 34. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S, Suruki R, Maskell J, Bonar K, Hilton E, Compton C.
    COPD; 2018 Apr 11; 15(2):177-184. PubMed ID: 29558236
    [Abstract] [Full Text] [Related]

  • 35. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
    Müllerová H, Hahn B, Simard EP, Mu G, Hatipoğlu U.
    Int J Chron Obstruct Pulmon Dis; 2019 Apr 11; 14():683-692. PubMed ID: 30962682
    [Abstract] [Full Text] [Related]

  • 36. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden.
    Sulku J, Janson C, Melhus H, Malinovschi A, Ställberg B, Bröms K, Högman M, Lisspers K, Hammarlund-Udenaes M, Nielsen EI.
    Int J Chron Obstruct Pulmon Dis; 2019 Apr 11; 14():2451-2460. PubMed ID: 31806954
    [Abstract] [Full Text] [Related]

  • 37. A systematic review of blood eosinophils and continued treatment with inhaled corticosteroids in patients with COPD.
    Dalin DA, Løkke A, Kristiansen P, Jensen C, Birkefoss K, Christensen HR, Godtfredsen NS, Hilberg O, Rohde JF, Ussing A, Vermehren C, Händel MN.
    Respir Med; 2022 Jul 11; 198():106880. PubMed ID: 35599064
    [Abstract] [Full Text] [Related]

  • 38. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY, Park HY, Kim EK, Lim SY, Rhee CK, Hwang YI, Oh YM, Lee SD, Park YB.
    Int J Chron Obstruct Pulmon Dis; 2016 Jul 11; 11():2797-2803. PubMed ID: 27877033
    [Abstract] [Full Text] [Related]

  • 39. Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis.
    Oshagbemi OA, Odiba JO, Daniel A, Yunusa I.
    Curr Drug Targets; 2019 Jul 11; 20(16):1670-1679. PubMed ID: 31393244
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.